Cargando…
Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART‐1) trial design
AIMS: Cardiopoiesis is a conditioning programme that aims to upgrade the cardioregenerative aptitude of patient‐derived stem cells through lineage specification. Cardiopoietic stem cells tested initially for feasibility and safety exhibited signs of clinical benefit in patients with ischaemic heart...
Autores principales: | Bartunek, Jozef, Davison, Beth, Sherman, Warren, Povsic, Thomas, Henry, Timothy D., Gersh, Bernard, Metra, Marco, Filippatos, Gerasimos, Hajjar, Roger, Behfar, Atta, Homsy, Christian, Cotter, Gad, Wijns, William, Tendera, Michal, Terzic, Andre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064644/ https://www.ncbi.nlm.nih.gov/pubmed/26662998 http://dx.doi.org/10.1002/ejhf.434 |
Ejemplares similares
-
Cardiopoietic stem cell therapy in ischaemic heart failure: long‐term clinical outcomes
por: Bartunek, Jozef, et al.
Publicado: (2020) -
Clinical development plan for regenerative therapy in heart failure
por: Terzic, Andre, et al.
Publicado: (2016) -
Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial
por: Bartunek, Jozef, et al.
Publicado: (2017) -
Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome
por: Arrell, D. Kent, et al.
Publicado: (2020) -
Secretome signature of cardiopoietic cells echoed in rescued infarcted heart proteome
por: Arrell, D. Kent, et al.
Publicado: (2021)